Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
New Phytol ; 239(5): 1651-1664, 2023 09.
Artículo en Inglés | MEDLINE | ID: mdl-37322611

RESUMEN

The continuous imbalance between nitrogen (N) and phosphorus (P) deposition is expected to shift many ecosystems from N- to P limitation. Extraradical hyphae of ectomycorrhizal (ECM) fungi play important roles in plant nutrient acquisition under nutrient deficiency. However, whether and how ECM hyphae enhance soil P availability to alleviate N-induced P deficiency remains unclear. We investigated the impacts of ECM hyphae on transformations among different soil P fractions and underlying mechanisms under N deposition in two ECM-dominated forests. Ectomycorrhizal hyphae enhanced soil P availability under N addition by stimulating mineralization of organic P (Po) and desorption and solubilization of secondary mineral P, as indicated by N-induced increase in positive hyphal effect on plant-available P pool and negative hyphal effects on Po and secondary mineral P pools. Moreover, ECM hyphae increased soil phosphatase activity and abundance of microbial genes associated with Po mineralization and inorganic P solubilization, while decreasing concentrations of Fe/Al oxides. Our results suggest that ECM hyphae can alleviate N-induced P deficiency in ECM-dominated forests by regulating interactions between microbial and abiotic factors involved in soil P transformations. This advances our understanding of plant acclimation strategies via mediating plant-mycorrhiza interactions to sustain forest production and functional stability under changing environments.


Asunto(s)
Micorrizas , Fósforo , Ecosistema , Hifa , Nitrógeno , Bosques , Micorrizas/fisiología , Minerales , Plantas , Suelo , Microbiología del Suelo
2.
Apoptosis ; 22(5): 647-661, 2017 05.
Artículo en Inglés | MEDLINE | ID: mdl-28229251

RESUMEN

Homocysteine (Hcy)-triggered endoplasmic reticulum (ER) stress-mediated endothelial cell apoptosis has been suggested as a cause of Hcy-dependent vascular injury. However, whether ER stress is the molecular mechanism linking Hcy and cardiomyocytes death is unclear. Taurine has been reported to exert cardioprotective effects via various mechanisms. However, whether taurine protects against Hcy-induced cardiomyocyte death by attenuating ER stress is unknown. This study aimed to evaluate the opposite effects of taurine on Hcy-induced cardiomyocyte apoptosis and their underlying mechanisms. Our results demonstrated that low-dose or short-term Hcy treatment increased the expression of glucose-regulated protein 78 (GRP78) and activated protein kinase RNA-like ER kinase (PERK), inositol-requiring enzyme 1 (IRE1), and activating transcription factor 6 (ATF6), which in turn prevented apoptotic cell death. High-dose Hcy or prolonged Hcy treatment duration significantly up-regulated levels of C/EBP homologous protein (CHOP), cleaved caspase-12, p-c-Jun N-terminal kinase (JNK), and then triggered apoptotic events. High-dose Hcy also resulted in a decrease in mitochondrial membrane potential (Δψm) and an increase in cytoplasmic cytochrome C and the expression of cleaved caspase-9. Pretreatment of cardiomyocytes with sodium 4-phenylbutyric acid (an ER stress inhibitor) significantly inhibited Hcy-induced apoptosis. Furthermore, blocking the PERK pathway partly alleviated Hcy-induced ER stress-modulated cardiomyocyte apoptosis, and down-regulated the levels of Bax and cleaved caspase-3. Experimental taurine pretreatment inhibited the expression of ER stress-related proteins, and protected against apoptotic events triggered by Hcy-induced ER stress. Taken together, our results suggest that Hcy triggered ER stress in cardiomyocytes, which was the crucial molecular mechanism mediating Hcy-induced cardiomyocyte apoptosis, and the adverse effect of Hcy could be prevented by taurine.


Asunto(s)
Apoptosis/efectos de los fármacos , Estrés del Retículo Endoplásmico/efectos de los fármacos , Miocitos Cardíacos/efectos de los fármacos , Taurina/administración & dosificación , Factor de Transcripción Activador 6/genética , Animales , Apoptosis/genética , Regulación de la Expresión Génica/efectos de los fármacos , Proteínas de Choque Térmico/genética , Homocisteína/toxicidad , Proteínas de la Membrana/genética , Miocitos Cardíacos/patología , Proteínas Serina-Treonina Quinasas/genética , Ratas
3.
PeerJ ; 4: e1993, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27547513

RESUMEN

Recently, selenium (Se) enriched mushrooms have been exploited as dietary Se supplements, but our knowledge of the metabolic process during the Se enrichment process is far from complete. In this study, the uptake, tolerance and reduction of selenite in a widely cultivated mushroom, Flammulina velutipes, was investigated. The results showed that pH variation (from 5.5-7.5), metabolic inhibitor (0.1 mM 2,4-DNP) and P or S starvation led to 11-26% decreases in the selenite uptake rate of F. velutipes. This indicates that a minor portion of the selenite uptake was metabolism dependent, whereas a carrier-facilitated passive transport may be crucial. Growth inhibition of F. velutipes initiated at 0.1 mM selenite (11% decrease in the growth rate) and complete growth inhibition occurred at 3 mM selenite. A selenite concentration of 0.03-0.1 mM was recommended to maintain the balance between mycelium production and Se enrichment. F. velutipes was capable of reducing selenite to elemental Se [Se(0)] including Se(0) nanoparticles, possibly as a detoxification mechanism. This process depended on both selenite concentration and metabolism activity. Overall, the data obtained provided some basic information for the cultivation of the selenized F. velutipes, and highlighted the opportunity of using mushrooms for the production of Se(0) nanoparticles.

4.
Environ Pollut ; 214: 282-289, 2016 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-27105164

RESUMEN

The hydro-dynamic conditions have been changed after the impoundment of Three Gorges Reservoir (TGR), which result in changes of phosphorus (P) distribution in sediments. To investigate the variation and storage of P in the surface sediments of the TGR, continuously and intermittently submerged sediment samples were collected from 14 sites in 2014, and P fractions were analyzed using a modified Hedley sequential extraction method. The results showed that the concentrations of total P (TP) (904 ± 105 mg/kg) in the sediments did not exhibit an apparent spatial trend. A decreasing trend of bioavailable P (Bio-P) concentration in the continuously submerged sediment (177 ± 29 mg/kg) was observed from Fuling to Zigui, while an opposite trend appeared in the intermittently submerged sediment (139 ± 49 mg/kg) from Jiangjin to Zigui. The water depth and sediment grain size had important implications for the variation of the Bio-P in the sediments along the TGR. After the full operation of the TGR, the concentration of TP in the intermittently submerged sediment from Fengjie to Zigui was significantly higher in 2014 compared with that in 2009. The continuously submerged sediment is a major P pool of the TGR with an annual Bio-P deposition flux of 2.14 × 10(4) t/a, of which 87% was retained in the reaches from Fuling to Zigui. Considering the slow release of P from the sediment (0.16-2.75 t/a), the sediment has been a P "sink" since the full operation of the TGR in 2010.


Asunto(s)
Sedimentos Geológicos/química , Fósforo/análisis , Contaminantes Químicos del Agua/análisis , China , Monitoreo del Ambiente , Ríos
5.
Parasit Vectors ; 6: 162, 2013 Jun 05.
Artículo en Inglés | MEDLINE | ID: mdl-23734964

RESUMEN

BACKGROUND: Schistosomiasis is a neglected tropical disease with high morbidity and mortality in the world. Currently, the treatment of this disease depends almost exclusively on praziquantel (PZQ); however, the emergence of drug resistance to PZQ in schistosomes makes the development of novel drugs an urgent task. Aldose reductase (AR), an important component that may be involved in the schistosome antioxidant defense system, is predicted as a potential drug target. METHODS: The tertiary structure of Schistosoma japonicum AR (SjAR) was obtained through X-ray diffraction method and then its potential inhibitors were identified from the Maybridge HitFinder library by virtual screening based on this structural model. The effects of these identified compounds on cultured adult worms were evaluated by observing mobility, morphological changes and mortality. To verify that SjAR was indeed the target of these identified compounds, their effects on recombinant SjAR (rSjAR) enzymatic activity were assessed. The cytotoxicity analysis was performed with three types of human cell lines using a Cell Counting Kit-8. RESULTS: We firstly resolved the SjAR structure and identified 10 potential inhibitors based on this structural model. Further in vitro experiments showed that one of the compounds, renamed as AR9, exhibited significant inhibition in the activity of cultured worms as well as inhibition of enzymatic activity of rSjAR protein. Cytotoxicity analysis revealed that AR9 had relatively low toxicity towards host cells. CONCLUSIONS: The work presented here bridges the gap between virtual screening and experimental validation, providing an effective and economical strategy for the development of new anti-parasitic drugs. Additionally, this study also found that AR9 may become a new potential lead compound for developing novel antischistosomal drugs against parasite AR.


Asunto(s)
Aldehído Reductasa/química , Antihelmínticos/aislamiento & purificación , Diseño de Fármacos , Inhibidores Enzimáticos/aislamiento & purificación , Proteínas del Helminto/química , Schistosoma japonicum/enzimología , Animales , Antihelmínticos/química , Antihelmínticos/farmacología , Bioensayo , Cristalografía por Rayos X , Evaluación Preclínica de Medicamentos/métodos , Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/farmacología , Locomoción/efectos de los fármacos , Conformación Proteica , Schistosoma japonicum/anatomía & histología , Schistosoma japonicum/efectos de los fármacos , Schistosoma japonicum/fisiología , Análisis de Supervivencia
6.
PLoS One ; 8(6): e64984, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23762275

RESUMEN

BACKGROUND: Schistosomiasis is a disease caused by parasitic worms and more than 200 million people are infected worldwide. The emergence of resistance to the most commonly used drug, praziquantel (PZQ), makes the development of novel drugs an urgent task. 3-oxoacyl-ACP reductase (OAR), a key enzyme involved in the fatty acid synthesis pathway, has been identified as a potential drug target against many pathogenic organisms. However, no research on Schistosoma japonicum OAR (SjOAR) has been reported. The characterization of the SjOAR protein will provide new strategies for screening antischistosomal drugs that target SjOAR. METHODOLOGY/PRINCIPAL FINDINGS: After cloning the SjOAR gene, recombinant SjOAR protein was purified and assayed for enzymatic activity. The tertiary structure of SjOAR was obtained by homology modeling and 27 inhibitor candidates were identified from 14,400 compounds through molecular docking based on the structure. All of these compounds were confirmed to be able to bind to the SjOAR protein by BIAcore analysis. Two compounds exhibited strong antischistosomal activity and inhibitory effects on the enzymatic activity of SjOAR. In contrast, these two compounds showed relatively low toxicity towards host cells. CONCLUSIONS/SIGNIFICANCE: The work presented here shows the feasibility of isolation of new antischistosomal compounds using a combination of virtual screening and experimental validation. Based on this strategy, we successfully identified 2 compounds that target SjOAR with strong antischistosomal activity but relatively low cytotoxicity to host cells.


Asunto(s)
3-Oxoacil-(Proteína Transportadora de Acil) Reductasa/aislamiento & purificación , Antihelmínticos/farmacología , Simulación por Computador , Descubrimiento de Drogas , Schistosoma japonicum/enzimología , 3-Oxoacil-(Proteína Transportadora de Acil) Reductasa/antagonistas & inhibidores , 3-Oxoacil-(Proteína Transportadora de Acil) Reductasa/genética , Animales , Muerte Celular/efectos de los fármacos , Clonación Molecular , Evaluación Preclínica de Medicamentos , Inhibidores Enzimáticos/farmacología , Genes de Helminto/genética , Proteínas del Helminto/antagonistas & inhibidores , Proteínas del Helminto/genética , Proteínas del Helminto/aislamiento & purificación , Células Hep G2 , Humanos , Cinética , Schistosoma japonicum/citología , Schistosoma japonicum/efectos de los fármacos , Schistosoma japonicum/ultraestructura , Relación Estructura-Actividad , Análisis de Supervivencia , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA